phase
human
clinic
studi
involv
therapeut
emerg
biodefens
pathogen
low
incid
sever
acut
respiratori
syndrom
coronaviru
sarscov
requir
minimum
preclin
evalu
efficaci
two
wellcharacter
robust
anim
model
thu
ferret
sarscov
model
evalu
period
day
follow
extens
optim
character
model
order
valid
clinic
histopatholog
virolog
immunolog
endpoint
ferret
infect
intranas
tcid
sarscov
show
higher
bodi
temperatur
dpi
sneez
dpi
lesion
dpi
decreas
wbclymphocyt
dpi
sarscov
detect
dpi
variou
tissu
excreta
neutral
antibodi
titer
rose
dpi
peak
dpi
dpi
one
group
challeng
tcid
sarscov
anamnest
respons
neutral
antibodi
evid
detect
viru
studi
support
valid
ferret
model
use
evalu
efficaci
potenti
therapeut
treat
sar
sever
acut
respiratori
syndrom
sar
caus
sarscoronaviru
sarscov
positivesens
singlestrand
rna
viru
drosten
et
al
kuiken
et
al
peiri
et
al
pulmonari
infect
sarscov
occur
age
group
averag
mortal
rate
howev
among
elderli
rate
chan
et
al
b
chiu
et
al
donnelli
et
al
tsui
et
al
potenti
sarscov
outbreak
still
warrant
sinc
palm
civet
guan
et
al
bat
li
et
al
implic
possibl
zoonot
reservoir
sarscovor
close
relat
sarslik
virus
discoveri
evalu
effect
therapeut
newli
emerg
clinic
diseas
sarscov
requir
welldefin
anim
model
sever
group
report
use
small
anim
model
may
reproduc
featur
sar
human
small
anim
model
particularli
mice
robert
et
al
wentworth
et
al
yang
et
al
hamster
robert
et
al
robert
et
al
provid
experiment
system
studi
infect
immun
pathogenesi
serv
use
tool
screen
vaccin
antivir
drug
howev
util
studi
clinic
progress
diseas
limit
inher
differ
small
mammal
human
anatom
structur
respiratori
physiolog
manifest
clinic
diseas
furthermor
fda
approv
vaccin
therapeut
treatment
emerg
diseas
sar
requir
demonstr
avail
onlin
wwwsciencedirectcom
virolog
wwwelseviercomlocateyviro
efficaci
least
two
anim
modelsa
rodent
nonrod
nonhuman
primat
use
model
studi
clinic
progress
evalu
treatment
sarscov
infect
diseas
pathogenesi
howev
animaltoanim
variabl
level
viral
replic
lung
tissu
sarscov
infect
african
green
monkey
cynomolgu
macaqu
haagman
osterhau
kuiken
et
al
lawler
et
al
osterhau
et
al
rhesu
macaqu
qin
et
al
row
et
al
tang
et
al
zhou
et
al
report
symptom
sarscov
infect
cynomolgu
macaqu
haagman
osterhau
kuiken
et
al
lawler
et
al
row
et
al
rhesu
macaqu
li
et
al
qin
et
al
includ
lethargi
skin
rash
respiratori
distress
interstiti
pneumonia
diffus
alveoli
damag
although
nonhuman
primat
model
mimic
infect
diseas
symptom
seen
human
expens
requir
special
hous
husbandri
practic
avail
facil
one
altern
nonrod
model
domest
ferret
mustela
putoriu
furo
ferret
commonli
use
anim
model
therefor
literatur
sourc
limit
howev
anim
shown
great
promis
reproduc
human
correl
diseas
influenza
preliminari
studi
show
domest
ferret
present
diseas
symptom
patholog
similar
observ
sarscov
infect
human
martina
et
al
cat
ferret
infect
sarscov
via
intratrach
rout
use
highviru
titer
tcid
uml
cat
show
clinic
symptom
except
shed
viru
wherea
ferret
show
classic
symptom
sar
includ
death
case
addit
shed
viru
martina
et
al
studi
suggest
ferret
could
develop
model
preclin
evalu
efficaci
sarscov
therapeut
overal
object
effort
develop
character
ferret
model
permiss
sarscov
infect
diseas
follow
intens
optim
dose
variou
endpoint
herein
report
valid
model
infect
challeng
day
studi
valid
standard
health
indic
endpoint
allow
comparison
clinic
manifest
sarscov
human
patient
includ
clinic
find
temperatur
mean
bodi
weight
hematolog
clinic
chemistri
paramet
gross
patholog
histopatholog
virolog
immunolog
assess
model
provid
insight
understand
mani
underli
featur
sar
diseas
human
promot
evalu
promis
therapeut
vaccin
ferret
divid
randomli
four
group
mockinfect
sarscov
infect
mockchalleng
sarscov
challeng
tabl
dose
sarscov
chosen
studi
base
upon
sever
smaller
studi
ferret
differ
challeng
dose
rang
tcid
ml
fig
gener
lower
dose
viru
produc
reproduc
result
lower
dose
viru
show
less
variat
level
viral
infect
lung
specif
higher
dose
tcid
ml
show
minim
infect
ferret
nasal
turbin
nt
variabl
lung
tcid
ml
dose
provid
highest
infect
reproduc
nt
lung
tissu
fig
dpi
ferret
mockinfect
group
group
ferret
inocul
intranas
serumfre
medium
without
viru
ferret
sarscov
infect
group
group
ferret
inocul
intranas
tcid
sarscov
dilut
serumfre
medium
dpi
nine
ferret
group
mockchalleng
serumfre
medium
group
eighteen
ferret
group
challeng
sarscov
group
ferret
observ
twice
daili
detail
record
pharmacolog
toxicolog
sign
symptom
includ
natur
onset
sever
durat
gross
visibl
chang
includ
limit
abnorm
circulatori
respiratori
excretori
behavior
neurolog
sign
symptom
addit
activ
score
alert
play
alert
play
stimul
alert
play
stimul
neither
alert
play
stimul
obtain
time
ferret
observ
predetermin
time
point
postinocul
describ
materi
method
ferret
three
ferret
group
four
group
euthan
specimen
collect
analys
viral
load
tcid
neutral
antibodi
viral
rna
rtpcr
chang
cytolog
immunohistochemistri
histopatholog
chang
clinic
patholog
chemistri
hematolog
describ
materi
method
subcutan
bodi
temperatur
clinic
observ
obtain
twice
daili
graph
temperatur
profil
fig
depict
mean
temperatur
four
groupsmockinfect
group
sarscov
infect
group
mockchalleng
group
sarscov
challeng
group
overal
mean
temperatur
four
group
within
normal
rang
ferret
inclus
three
ferret
group
abnorm
low
bodi
temperatur
dpi
sarscov
infect
group
group
temperatur
increas
evid
dpi
statist
analysi
show
signific
temperatur
increas
dpi
p
valu
respect
compar
temperatur
mockinfect
ferret
group
significantli
lower
temperatur
sarscov
infect
ferret
observ
dpi
interpret
find
unclear
result
support
bodi
temperatur
use
marker
assess
sarscov
infect
ferret
anim
alert
play
activ
score
except
one
ferret
group
discuss
later
clinic
observ
focus
sneez
fever
diarrhea
mortal
morbid
tabl
ferret
mockinfect
group
show
sneez
ferret
among
sarscov
infect
ferret
group
sneez
observ
earli
dpi
late
dpi
studi
sneez
observ
dp
one
ferret
among
infect
ferret
show
sneez
ocular
discharg
two
symptom
occur
differ
time
sneez
observ
among
sarscov
challeng
ferret
group
mockchalleng
ferret
group
tabl
diarrhea
also
observ
ferret
sarscov
infect
mockinfect
group
one
ferret
group
diarrhea
dpi
one
ferret
group
show
diarrhea
dpi
howev
five
ferret
group
mortal
morbid
ferret
examin
twice
per
day
morn
afternoon
day
studi
includ
identifi
dead
weak
moribund
anim
document
onset
abnorm
clinic
sign
moribund
anim
defin
exhibit
seizur
sever
depress
respiratori
distress
sever
dyspnea
difficult
labor
breath
recumb
weak
unrespons
touch
extern
stimuli
greater
loss
bodi
weight
bodi
temperatur
indic
shock
total
anorexia
durat
longer
h
one
ferret
group
euthan
earli
develop
moribund
state
symptom
includ
diarrhea
dehydr
hypothermia
decreas
food
intak
diseas
anim
unrel
sarscov
infect
determin
absenc
viru
viral
rna
discuss
later
section
bodi
weight
taken
prior
mock
viral
infect
challeng
necropsi
group
signific
chang
tabl
mean
weight
observ
within
group
data
shown
respect
weight
whole
lung
liver
heart
obtain
necropsi
ferret
ratio
group
mean
organ
weight
group
mean
bodi
weight
mean
organ
wtmean
bodi
wt
calcul
group
mean
lung
weight
bodi
weight
show
increas
background
group
ferret
sacrif
studi
dpi
data
shown
howev
increas
statist
signific
p
remark
differ
mean
liver
heart
weight
data
shown
group
group
viral
burden
lung
nasal
turbin
upper
lower
trachea
duodenum
liver
colon
determin
tcid
signific
viral
titer
detect
lung
nasal
turbin
tissu
infect
anim
fig
viral
titer
lung
tissu
log
background
level
tcid
uml
dpi
increas
log
background
level
tcid
uml
dpi
fig
viral
titer
nasal
turbin
increas
log
background
level
tcid
uml
dpi
decreas
slightli
dpi
prior
drop
day
pi
tcid
uml
fig
sampl
liver
lysat
high
background
nois
level
made
measur
viral
titer
difficult
howev
viru
titer
liver
sampl
background
level
data
shown
similarli
duodenum
upper
trachea
lower
trachea
detect
viru
titer
data
shown
viru
shed
measur
nasal
pharyng
rectal
sampl
signific
viral
titer
detect
nasal
pharyng
fluid
infect
anim
fig
log
background
level
tcid
ml
note
viral
titer
post
challeng
dpi
gener
near
background
fig
suggest
viru
unabl
reestablish
infect
previous
infect
anim
total
rna
isol
tissu
homogen
fluid
excreta
swab
sampl
analyz
use
primer
specif
sarscov
nucleocapsid
gene
group
viral
rna
detect
nasal
pharyng
swab
nasal
turbin
lung
homogen
major
ferret
dpi
tabl
overal
viral
rna
level
correl
viral
tcid
titer
individu
anim
rectal
swab
day
five
singl
ferret
posit
viral
rna
correl
tcid
result
anim
dpi
one
ferret
remain
rtpcr
posit
viru
titer
anim
background
level
group
viral
rna
detect
bodi
fluid
tissu
sampl
tabl
mention
previous
one
ferret
group
exhibit
seriou
health
condit
cours
studi
ferret
diarrhea
dpi
studi
dpi
ferret
exhibit
dehydr
hypothermia
decreas
food
intak
declar
moribund
euthan
neither
viru
viral
rna
detect
nasal
colon
duodenum
liver
lung
lower
trachea
sampl
ferret
thu
ill
sarscov
infect
level
neutral
antibodi
sarscov
evalu
four
group
fig
neutral
antibodi
detect
group
group
neutral
antibodi
increas
dpi
reach
peak
titer
u
dpi
decreas
slightli
u
dpi
challeng
fig
tempor
cours
neutral
antibodi
correl
decreas
viral
burden
lung
nasal
turbin
nasal
pharyng
swab
sampl
dpi
follow
sarscov
challeng
dpi
anamnest
respons
evid
group
anim
abrupt
increment
neutral
antibodi
u
peak
data
point
studi
titer
stay
high
two
week
fell
u
dpi
section
lung
lobe
left
cranial
left
caudal
right
cranial
right
middl
trachea
colon
duodenum
liver
stain
hematoxylin
eosin
h
e
stain
evalu
direct
microscop
observ
lesion
grade
subject
blindli
scale
minim
mild
moder
mark
distribut
modifi
focal
f
multifoc
diffus
lesion
relat
sarscov
infect
identifi
lung
group
ferret
dpi
sever
lesion
evid
dpi
fig
compar
lung
lesion
group
anim
fig
primari
sarsrel
lesion
identifi
group
anim
consist
lymphohistiocyt
bronchointerstiti
pneumonia
fig
addit
mark
increas
number
lymphocyt
macrophag
associ
pulmonari
vasculatur
connect
tissu
surround
conduct
airway
fig
observ
lung
group
fig
sever
affect
anim
develop
mild
moder
involv
bronchi
lumin
accumul
mucu
neutrophil
infect
anim
also
small
collect
granulocyt
primarili
neutrophil
near
bronchioloalveolar
junction
histolog
lesion
relat
sarscov
detect
among
challeng
ferret
result
shown
lesion
present
mani
anim
sarscov
expos
unexpos
group
interpret
background
lesion
unrel
sarscov
exposur
consist
congest
minim
mild
peribronchovascular
accumul
lymphocyt
minim
mild
bronchiol
baselin
valu
differ
clinic
chemistri
paramet
measur
prestudi
serum
sampl
obtain
ferret
sampl
analyz
level
alanin
aminotransferas
alkalin
phosphatas
albumin
lactat
dehydrogenas
aspart
aminotransferas
total
bilirubin
blood
urea
nitrogen
calcium
chlorid
cholesterol
creatin
kinas
creatinin
gamma
glutamyl
transferas
glucos
phosphoru
potassium
sodium
total
protein
triglycerid
globulin
albuminglobulin
group
mean
valu
compar
identifi
trend
suggest
sarscov
infect
valu
infect
ferret
compar
baselin
examin
signific
differ
lactat
dehydrogenas
level
serum
group
significantli
higher
dpi
group
data
shown
appear
diseas
marker
worthi
investig
although
gamma
glutamyl
transferas
ggt
express
ferret
level
group
ferret
gener
higher
baselin
valu
ggt
neg
low
henc
includ
comparison
serum
level
ggt
show
differ
group
signific
result
shown
howev
small
sampl
size
n
n
may
factor
outcom
observ
studi
therefor
level
ggt
might
warrant
investig
paramet
result
shown
significantli
differ
mock
infect
group
result
shown
gener
speak
major
symptom
group
ferret
dehydr
dehydr
might
good
diseas
marker
caution
need
taken
interpret
clinic
chemistri
observ
baselin
valu
hematolog
paramet
includ
white
blood
cell
count
red
blood
cell
count
hemoglobin
concentr
hematocrit
mean
corpuscular
volum
mean
corpuscular
hemoglobin
mean
corpuscular
hemoglobin
concentr
neutrophil
lymphocyt
monocyt
eosinophil
basophil
leucocyt
reticulolocyt
obtain
prestudi
blood
sampl
obtain
ferret
group
mean
valu
predetermin
baselin
valu
prior
day
plot
graph
identifi
trend
correl
sarscov
infect
fig
valu
sarscov
infect
ferret
group
compar
mockinfect
challeng
group
baselin
level
white
blood
cell
significantli
lower
dpi
fig
group
blood
level
lymphocyt
fig
lower
dpi
margin
higher
dpi
compar
baselin
valu
level
neutrophil
group
fig
gener
higher
baselin
signific
group
show
level
similar
baselin
measur
fig
hematolog
paramet
significantli
differ
baselin
valu
howev
may
need
confirm
futur
experi
use
larger
sampl
size
patient
infect
sarscov
show
gener
influenzalik
symptom
fever
headach
malais
cough
loss
appetit
diarrhea
myalgia
bitnun
et
al
booth
et
al
chiu
et
al
drosten
et
al
kuiken
et
al
leung
et
al
peiri
et
al
older
adult
patient
infect
sarscov
often
develop
sever
febril
pneumonia
exampl
see
contrast
sar
adult
sar
young
children
tend
rel
mild
diseas
adolesc
experi
signific
respiratori
diseas
similar
adult
younger
children
gener
bitnun
et
al
symptom
myalgia
chill
headach
common
adult
usual
absent
children
wong
fok
children
shorter
cours
ill
gener
develop
signific
pulmonari
diseas
requir
assist
ventil
bitnun
et
al
chiu
et
al
hon
et
al
leung
et
al
leung
et
al
puthucheari
et
al
adult
children
appear
similar
level
sarscov
viremia
associ
infect
impli
level
viral
replic
similar
group
ng
et
al
adult
sar
significantli
increas
serum
level
inflammatori
cytokin
chemokin
huang
et
al
zhang
et
al
activ
inflammatori
cytokin
children
sar
may
less
dramat
thu
immun
respons
may
account
variat
sar
sever
age
group
develop
anim
model
reflect
variat
human
popul
challeng
howev
note
sever
paramet
common
mani
case
temperatur
diarrhea
viremia
neutral
antibodi
henc
sought
discov
anim
model
display
symptom
ferret
belong
order
carnivora
famili
mustelida
relat
mink
otter
weasel
domest
european
ferret
mustela
putoriu
furo
domest
thousand
year
ball
ferret
uniqu
applic
includ
studi
human
influenza
renegar
smith
sweet
peptic
ulcer
diseas
del
giudic
et
al
fox
et
al
addit
mani
basic
research
applic
ferret
activ
investig
nonrod
model
drug
develop
fox
et
al
recent
ferret
explor
model
sar
howev
report
literatur
show
appar
conflict
data
regard
infect
pathogenesi
ferret
sarscov
primarili
differ
studi
design
age
anim
endpoint
examin
martina
et
al
shown
ferret
support
sarscov
replic
develop
pulmonari
lesion
martina
et
al
weingartl
et
al
report
ferret
remain
asymptomat
presenc
sarscov
replic
weingartl
et
al
herein
demonstr
ferret
suitabl
model
permiss
sarscov
infect
show
clinic
relev
indic
ill
diseas
progress
clinic
show
temperatur
increas
sneez
challeng
anim
fever
one
diseas
marker
sarscov
infect
human
bitnun
et
al
booth
et
al
ksiazek
et
al
kuiken
et
al
tsui
et
al
wong
fok
ferret
temperatur
increas
signific
dpi
sneez
consist
observ
ferret
dpi
tabl
observ
mockinfect
challeng
ferret
gener
sarscov
dose
use
anim
model
report
date
rang
tcid
intranas
infect
dose
use
studi
reach
similar
viru
titer
use
higher
dose
report
detect
signific
level
sarscov
lung
nasal
turbin
nasal
swab
pharyng
swab
sampl
infect
anim
viru
replic
could
detect
dpi
highest
peak
viru
replic
detect
upper
respiratori
region
nasal
turbin
follow
lower
respiratori
region
lung
detect
viral
rna
rtpcr
nasal
pharyng
swab
dpi
gener
anim
model
show
peak
day
viral
rna
lung
nasal
turbin
sampl
dpi
ferret
infect
tcid
sustain
viral
replic
tcid
ml
dpi
martina
et
al
ter
meulen
et
al
show
peak
day
infect
dpi
lung
ter
meulen
et
al
studi
use
sarscov
strain
studi
report
weingartl
et
al
czub
et
al
howev
show
much
longer
persist
viral
rna
lung
pharyng
fece
sampl
czub
et
al
weingartl
et
al
one
promis
model
sarscov
pathogenesi
rodent
golden
syrian
hamster
show
sustain
viral
replic
nasal
turbin
lung
robert
et
al
intranas
inocul
tcid
sarscov
peak
viral
replic
lung
occur
dpi
clear
dpi
howev
viral
titer
nasal
turbin
fold
lower
lung
detect
dpi
robert
et
al
ferret
studi
viral
titer
nasal
turbin
higher
five
log
background
lung
viru
also
detect
spleen
liver
hamster
robert
et
al
contrast
detect
viru
viral
rna
liver
ferret
primari
sarscov
infectionrel
lesion
ferret
model
lymphohistiocyt
bronchointerstiti
pneumonia
observ
day
exposur
addit
mark
increas
number
lymphocyt
macrophag
associ
pulmonari
vasculatur
connect
tissu
surround
conduct
airway
kind
patholog
present
also
observ
sarscov
infect
nonhuman
primat
correl
milder
syndrom
sarscov
infect
human
lawler
et
al
qin
et
al
rel
increas
lung
weight
although
signific
due
small
sampl
size
observ
dpi
infect
group
result
correspond
period
sneez
observ
occurr
immun
patholog
concern
develop
effect
vaccin
sar
czub
et
al
diseaseenhanc
antibodi
may
induc
natur
viral
infect
demonstr
dengu
felin
coronavirus
green
rothman
smith
sweet
olsen
et
al
antibodi
spike
protein
felin
coronavirus
involv
antibodydepend
enhanc
infect
passiv
transfer
sera
sarscov
infect
mice
provid
protect
subsequ
challeng
absenc
histopatholog
chang
lung
challeng
group
indic
absenc
immun
patholog
ferret
increas
neutral
antibodi
dpi
correl
decreas
viral
burden
observ
lung
nasal
turbin
nasal
swab
pharyng
swab
sampl
upon
challeng
one
month
primari
infect
signific
increas
antibodi
titer
observ
antibodi
titer
higher
seen
primari
infect
boost
antibodi
titer
may
contribut
lower
viral
burden
observ
challeng
therefor
neutral
antibodi
consid
correl
protect
sarscov
infect
anim
summari
sar
ferret
model
endpoint
identifi
herein
provid
platform
investig
immun
respons
pathogenesi
well
evalu
efficaci
potenti
antivir
drug
vaccin
sarscov
diseas
sarscov
strain
provid
dr
heinz
feldman
univers
manitoba
sarscov
seed
stock
titer
tcid
uml
propag
vero
cell
atcc
vero
crl
seed
stock
dilut
design
titer
use
sarscov
tcid
neutral
antibodi
assay
male
ferret
mustela
putoriu
furo
week
age
purchas
tripl
f
farm
sayr
pa
ferret
screen
tripl
f
farm
standard
panel
pathogen
southern
research
institut
influenza
virus
use
standard
hemagglutinin
assay
stephenson
et
al
influenzafre
ferret
use
studi
prestudi
weight
ferret
rang
kg
kg
ferret
uniqu
identifi
ear
tag
subcutan
transpond
biomed
data
system
inc
seaford
delawar
also
util
measur
bodi
temperatur
anim
hous
anim
manipul
approv
anim
care
committe
met
anim
care
guidelin
anim
work
perform
contain
facil
ferret
divid
randomli
four
group
base
upon
sarscov
infect
mock
infect
challeng
viru
mock
inocul
tabl
dpi
twentyfour
ferret
group
inocul
intranas
serumfre
medium
fortytwo
group
sarscov
tcid
ml
dilut
medium
dpi
nine
ferret
group
inocul
serumfre
medium
eighteen
ferret
group
challeng
inocul
sarscov
tcid
dilut
medium
prior
instil
mock
viru
inoculum
ferret
anesthet
ml
inoculum
administ
intranas
dropwis
deliveri
per
nare
ferret
observ
twice
daili
detail
record
clinic
sign
symptom
morbid
mortal
includ
natur
onset
sever
durat
gross
visibl
chang
mockinfect
group
group
three
ferret
sequenti
sacrif
dp
first
challeng
sarscov
infect
group
challeng
group
group
four
group
three
group
ferret
sequenti
sacrif
dp
first
challeng
tissu
specimen
includ
lung
nasal
turbin
upper
lower
trachea
duodenum
liver
colon
differ
swab
sampl
includ
nasal
swab
pharyng
swab
rectal
swab
well
blood
collect
variou
patholog
virolog
immunolog
test
tissu
sampl
homogen
final
wtv
suspens
complet
dmem
clarifi
low
speed
centrifug
min
viru
titer
determin
vero
cell
monolay
grown
plate
vero
cell
seed
plate
incub
overnight
co
incub
serial
dilut
tissu
suspens
ad
well
quadrupl
format
plate
incub
co
incub
day
cytopath
effect
cpe
observ
microscop
magnif
viru
titer
express
tcid
unit
per
gram
tissu
lower
limit
detect
tcid
ug
neutral
test
serum
sampl
twofold
dilut
initi
final
dilut
mix
tcid
ml
viru
incub
overnight
perform
duplic
follow
morn
virusserum
mixtur
inocul
vero
cell
seed
previous
prepar
inocul
plate
incub
co
incub
day
cpe
viru
observ
microscop
magnif
total
rna
extract
experiment
sampl
tissu
fluid
homogen
suspens
describ
trizol
ls
reagent
invitrogen
carlsbad
ca
accord
manufactur
instruct
dri
rna
pellet
resuspend
nucleasefre
water
store
rtpcr
amplif
carri
rna
measur
quantiti
qualiti
use
experion
autom
electrophoresi
system
biorad
rna
extract
perform
bsl
laboratori
revers
transcript
reaction
perform
use
superscript
iiirevers
transcriptas
invitrogen
carlsbad
ca
random
primer
reaction
mixtur
includ
ng
random
primer
total
rna
sampl
dntp
mm
mixtur
heat
min
place
ice
min
follow
compon
ad
per
reaction
first
strand
buffer
dtt
rnase
recombin
rnase
inhibitor
superscript
iii
rt
invitrogen
rt
reaction
carri
min
follow
incub
min
inactiv
enzym
min
remov
rna
mixtur
e
coli
rnase
h
ad
incub
anoth
min
cdna
sampl
store
use
pcr
andor
quantit
realtim
pcr
experiment
sampl
posit
control
sarscov
strain
duplic
cdna
sampl
made
total
rna
sampl
primer
sarscov
strain
use
quantifi
amount
viral
rna
present
rt
sampl
primer
specif
nucleocapsid
n
gene
sarscov
genbank
access
primer
sequenc
use
pcr
detect
follow
sarsnforward
aga
atg
gag
gac
gca
sarsnrevers
gtg
aac
caa
gac
gca
appli
biosystem
foster
citi
ca
cdna
sampl
amplifi
reaction
contain
high
fidel
pcr
buffer
invitrogen
forward
revers
primer
final
mm
mgso
mm
final
mm
dntp
mm
unit
hi
fidel
taq
polymeras
pcr
optim
reaction
incub
min
follow
cycl
maintain
final
reaction
set
thin
shell
ml
pcr
tube
reaction
run
mj
research
thermal
cycler
biorad
pcr
product
electrophores
nusiev
agaros
gel
invitrogen
necropsi
ml
whole
blood
collect
plastic
goldtop
bd
vacutain
gel
tube
closur
ml
draw
bd
franklin
lake
nj
blood
allow
clot
centrifug
minimum
min
serum
held
analyz
serum
sampl
ferret
analyz
use
hitachi
analyz
follow
manufactur
manual
sampl
analyz
level
alanin
aminotransferas
alkalin
phosphatas
albumin
lactat
dehydrogenas
aspart
aminotransferas
bilirubintot
blood
urea
nitrogen
calcium
chlorid
cholesterol
creatin
kinas
creatinin
gamma
glutamyl
transferas
glucos
phosphoru
potassium
sodium
total
protein
triglycerid
globulin
albuminglobulin
baselin
valu
paramet
obtain
prestudi
serum
sampl
obtain
ferret
necropsi
ml
whole
blood
collect
plastic
lavendertop
bd
tube
closur
ml
draw
bd
franklin
lake
nj
contain
edta
anticoagul
whole
blood
sampl
kept
room
temperatur
analyz
blood
sampl
ferret
analyz
use
advia
white
blood
cell
count
red
blood
cell
count
hemoglobin
concentr
hematocrit
mean
corpuscular
volum
mean
corpuscular
hemoglobin
mean
corpuscular
hemoglobin
concentr
neutrophil
lymphocyt
monocyt
eosinophil
basophil
leucocyt
reticulolocyt
baselin
valu
paramet
obtain
prestudi
blood
sampl
obtain
ferret
ferret
unidentifi
speci
advia
bayer
protocol
state
sampl
run
use
dog
speci
select
differ
normal
erythrocyt
dog
ferret
lead
mani
ferret
sampl
flag
microcytosi
andor
hypochromasia
dog
mcv
normal
rang
fl
ferret
mcv
normal
rang
fl
dog
mchc
normal
rang
gdl
ferret
mchc
normal
rang
gdl
howev
manual
smear
review
also
suggest
substant
erythrocyt
anomali
thu
flag
may
disregard
studi
mockinfect
sarscov
infect
ferret
euthan
trachea
lung
remov
en
bloc
left
cranial
lcr
left
caudal
lcd
right
cranial
rcr
right
middl
rmi
lung
lobe
inflat
via
tracheal
cannula
paraformaldehyd
approxim
normal
volum
inflat
lung
immers
paraformaldehyd
allow
fix
minimum
h
section
trachea
liver
duodenum
colon
also
fix
paraformaldehyd
subsequ
histopatholog
fix
tissu
wash
pb
process
routin
paraffin
embed
tissu
section
stain
hematoxylin
eosin
h
e
assess
histopatholog
chang
respons
sarscov
infect
multipl
tissu
section
examin
veterinari
pathologist
histopatholog
chang
assess
sever
minim
mild
moder
mark
distribut
focal
multifoc
diffus
definit
follow
bronchiol
mix
histiocyt
granulocyt
inflamm
bronchiol
character
accumul
histiocyt
eosinophil
andor
neutrophil
vari
proport
wall
bronchiol
bronchioloalveolar
junction
bronchiti
suppur
increas
mucu
bronchial
epitheli
hyperplasia
inflamm
bronchi
character
transmigr
neutrophil
bronchial
wall
lumin
accumul
neutrophil
mucu
variabl
hyperplasia
bronchial
epithelium
bronchointerstiti
pneumonia
mononuclear
type
ii
cell
hyperplasia
inflamm
bronchiol
adjac
alveoli
character
infiltr
lymphocyt
macrophag
bronchiolar
alveolar
septal
wall
associ
alveoli
occasion
apoptoticnecrot
debri
bronchiolar
epitheli
cell
vari
appear
hypertrophiedhyperplast
flatten
attenu
inflamm
often
associ
mild
type
ii
cell
hyperplasia
variabl
atypia
infrequ
binucl
cell
perivascular
lymphoid
aggreg
accumul
lymphocyt
lesser
macrophag
adjac
sometim
cuf
pulmonari
blood
vessel
peribronchi
lymphoid
hyperplasia
accumul
lymphocyt
lesser
macrophag
bronchial
andor
bronchiolar
wall
subjac
connect
tissu
euthanasia
artifact
foci
poorli
stain
tissu
loss
differenti
stain
loss
nuclear
cytoplasm
detail
numer
data
obtain
conduct
studi
subject
calcul
group
mean
standard
deviat
differ
group
mean
analyz
anova
test
appropri
post
test
p
valu
less
consid
statist
signific
valu
mean
se
low
number
ferret
per
group
n
made
statist
calcul
signific
certain
instanc
clinic
chemistri
hematolog
studi
group
mean
compar
baselin
valu
indic
text
